Skip to main content

Oaktree Acquisition Corp. III Life Sciences

OACC
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002029769

No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 51 institutions reported holding it in 13F filings for Q2 2026, worth $181.5M in total; no superinvestor holds it.

Other share classesOACCUOACCW

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Oaktree Acquisition Corp. III Life Sciences insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Oaktree Acquisition Corp. III Life Sciences, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Oaktree Acquisition Corp. III Life Sciences
NameTitleLast reported holdingLast filingFilings, past year
Oaktree Capital Management LP10% Owner583,981Oct 31, 20240
BROOKFIELD Corp10% Owner583,981Oct 31, 20240
Oaktree Capital Group Holdings GP, LLC10% Owner583,981Oct 31, 20240
Oaktree Capital Group Holdings, L.P.10% Owner583,981Oct 31, 20240
Oaktree Capital Holdings, LLC10% Owner583,981Oct 31, 20240
Oaktree Capital Management GP, LLC10% Owner583,981Oct 31, 20240
BAM Partners Trust10% Owner583,981Oct 31, 20240
Brookfield Asset Management Ltd.10% Owner583,981Oct 31, 20240
Oaktree Acquisition Holdings III LS GP, Ltd.10% Owner583,981Oct 31, 20240
Oaktree Acquisition Holdings III LS, LLC10% Owner583,981Oct 31, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

No insider trades match these filters.